OxiWear announced it successfully closed a pre-seed funding round at $1.25M, oversubscribed above its goal of $750,000. OxiWear is a medtech and sportstech startup company developing an ear-wearable pulse oximeter for 24-hour, continuous oxygen monitoring, and low-oxygen alerting.

OxiWear submitted its FDA 510K (II) pre-submission package on November 12 with the assistance of MethodSense, our FDA filing consultants. The company received receipt confirmation along with its official FDA docket number. The team is scheduled for its pre-review meeting in early February 2022.

OxiWear participated in the first-ever bootcamp for Asian sports and health tech startups in partnership with leAD and Toyoshima. The seminar included product and company introductions by Xenoma and Euphoria. A panel discussion with the CEO’s of KinoTek and OxiWear was facilitated by Alexander Bente, Principal, ADvantage Sports Tech Fund.

OxiWear attended the MassMEDIC BIOMEDevice Boston 2021 convention held on September 21-22, 2021. We were thrilled to be chosen by Formlabs to receive a Formlabs3, 3D-printer package, as part of the company’s diversity and inclusion program in support of our founder and CEO. We look forward to using this new printer to assist us with designing and testing our product.

After a month of virtual programming, the OxiWear team started their in-person experience with the leAD Sports & Health Tech accelerator in Lake Nona, Florida. The kick-off event was hosted on September 13, 2021, and included the new cohort companies, OxiWear, Kutai, IndiFit, Point, Sugi, and Flumina. The team enjoyed learning about the accelerator program as well as touring the Lake Nona Performance Sports Arena and Beep (an autonomous transportation company).

Shavini Fernando competed in the TiE Women Global Pitch Competition hosted by the TiE DC chapter on September 1, 2021.